A practical reference on Reversed-phase HPLC: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-01-31 and is reviewed periodically as new material appears.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
| Property | Value | Notes |
|---|---|---|
| Molecular weight, DAC form | About 3647 Da | Varies with salt form |
| Molecular weight, non-DAC form | About 3358 Da | MOD GRF(1-29) |
| Solubility class | Water soluble | Also dissolves in polar solvents |
| Reported half-life, DAC form | About five to eight days | Values from human studies |
| Common synonyms | CJC-1295; MOD GRF(1-29) | Name depends on variant |
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.
Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.
Reconstitution is typically performed with sterile water or bacteriostatic water, added slowly against the vial wall. The resulting solution should be clear and colorless; cloudiness or visible particles suggest a problem with the material or the diluent. Once in solution, the peptide is less stable than the dry powder. Refrigerated storage at two to eight degrees Celsius is common for short-term holding, while freezing aliquots is described for longer periods.
Electrical stimulation using implantable devices came into modern usage in the 1980s, and its techniques and applications have continued to develop and expand. These are methods where an operation is required to position an electrode. The stimulator, with the battery, similar to a pacemaker, may also be implanted, or may remain outside the body. In general, neuromodulation systems deliver electrical currents and typically consist of the following components: An epidural, subdural, or parenchymal electrode placed via minimally invasive needle techniques (so-called percutaneous leads) or an open surgical exposure to the target (surgical "paddle" or "grid" electrodes), or stereotactic implants for the central nervous system, and an implanted pulse generator (IPG). Depending on the distance from the electrode access point, an extension cable may also be added into the system. The IPG can have either a non-rechargeable battery needing replacement every 2–5 years (depending on stimulation parameters) or a rechargeable battery that is replenished via an external inductive charging system. Although most systems operate via delivery of a constant train of stimulation, there has recently been an emergence of so-called "feed-forward" stimulation, in which the device's activation is contingent on a physiological event, such as an epileptic seizure. In this circumstance, the device is activated and delivers a desynchronizing pulse to the cortical area that is undergoing an epileptic seizure.
== War period, 1938–1945 == When the committee was outlawed in September 1937, six of its members were deported, its president Amin al-Husayni managed to escape arrest and went into exile in Beirut. Jamal al-Husayni escaped to Syria. Three other members were deported to the Seychelles, and other members moved into voluntary exile in neighbouring countries. Al-Hadi, who was out of the country at the time, was not allowed to return. Membership of the outlawed committee had dwindled to Jamal al-Husayni (acting chairperson), Husayn al-Khalidi (secretary), Ahmed Hilmi Pasha and Emil Ghuri. For all practical purposes, the committee ceased to exist, however, this brought little change in the structure of Arab political life and the Palestinian revolt continued. With the indications of a new European war on the horizon, and in an endeavor to resolve the inter-communal issues in Palestine, the British government proposed in late 1938 a conference in London of the two Palestinian communities. Some Arab leaders welcomed the proposed London Conference but indicated that the British would need to deal with the disbanded Arab Higher Committee and with Amin al-Husayni. On 23 November 1938, the Colonial Secretary, Malcolm MacDonald, repeated his refusal to allow Amin al-Husayni to be a delegate, but was willing to allow the five Palestinian leaders held in the Seychelles to take part in the conference.
There are conflicting recommendations regarding whether to change the dosing of oral acetylcysteine after the administration of activated charcoal, and even whether the dosing of acetylcysteine needs to be altered at all. Intravenous acetylcysteine has no interaction with activated charcoal. Inducing vomiting with syrup of ipecac has no role in paracetamol overdose because the vomiting it induces delays the effective administration of activated charcoal and oral acetylcysteine. Liver injury is extremely rare after acute accidental ingestion in children under 6 years of age. Children with accidental exposures do not require gastrointestinal decontamination with either gastric lavage, activated charcoal, or syrup of ipecac.
Orenetide (INNTooltip International Nonproprietary Name; developmental code name BP101, proposed brand names Libicore and Desirix), also known as Thr-Lys-Pro-Arg-Pro or as so-called "female Viagra", is a synthetic small peptide drug which is under development for the treatment of female sexual dysfunction, or more specifically hypoactive sexual desire disorder (HSDD). It is taken intranasally as a nasal spray. The mechanism of action of orenetide has not been fully elucidated and is unknown. It was inactive at a panel of 98 G protein-coupled receptors (GPCRs), including serotonin, dopamine, and melanocortin receptors, among others. However, at high concentrations in vitro, it inhibited selected GABAA receptors, which may be involved in its effects. Relatedly, it has been labeled in some sources as a "GABAA receptor antagonist". The drug produces pro-sexual effects in rodents, with these effects appearing to be mediated in the medial preoptic area. It is described as a potential first-in-class medication. The drug was originated by Ivix and is under development by Ovoca Bio. As of January 2021, it is in the preregistration phase of development. In August 2023, it was announced that orenetide had failed to show efficacy for sexual desire or sexual distress in a large dose-ranging phase 2 clinical trial for treatment of HSDD. Shares of Ovoca Bio fell by as much as 82% following the announcement. Ovoca Bio is Ireland-based and orenetide has been developed in Australia, New Zealand, and Russia.
=== Early detection === From May to August 1939 the LZ130 Graf Zeppelin II made flights along Britain's North Sea coast to investigate the 100-metre-high radio towers that were being erected from Portsmouth to Scapa Flow. LZ130 performed a series of radiometric tests and took photographs. German sources report the 12 m Chain Home signals were detected and suspected to be radar; however, the chief investigator was not able to prove his suspicions. Other sources are said to report different results. During the Battle of France, the Germans observed 12 m pulse signals on the western front without being able to recognize their origin and purpose. In mid-June 1940, the Deutsche Versuchsanstalt für Luftfahrt (DVL, German Aeronautic Research Institute) set up a special group under the direction of Professor von Handel and found out that the signals originated from the installations on the coast of the English Channel. Their suspicions were finally proven in the aftermath of the Battle of Dunkirk, when the British were forced to abandon a mobile gun-laying radar (GL Mk. I) station in Normandy. Wolfgang Martini's team of specialists was able to determine the operation of the system. GL was a rather crude system of limited effectiveness, and this led the Germans to have a dim view of British radar systems. However, an effective system requires more than just the radar; plotting and reporting are equally important, and this part of the system was fully developed in Chain Home.
Sources: en.wikipedia.org
In 1960 Dyson wrote a short paper for the journal Science titled "Search for Artificial Stellar Sources of Infrared Radiation". In it he speculated that a technologically advanced extraterrestrial civilization might surround its native star with artificial structures to maximize the capture of the star's energy. Eventually, the civilization would enclose the star, intercepting electromagnetic radiation with wavelengths from visible light downward and radiating waste heat outward as infrared radiation. One method of searching for extraterrestrial civilizations would be to look for large objects radiating in the infrared range of the electromagnetic spectrum.
== External links == Clinical trial number NCT02964104 for "A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin 287 Once Weekly in Subjects With Type 2 Diabetes" at ClinicalTrials.gov Clinical trial number NCT04460885 for "A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 1)" at ClinicalTrials.gov Clinical trial number NCT04795531 for "A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3) (ONWARDS 3)" at ClinicalTrials.gov Clinical trial number NCT04770532 for "A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin (ONWARDS 2)" at ClinicalTrials.gov Clinical trial number NCT04880850 for "A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)" at ClinicalTrials.gov
=== Judges' Costumes === Episode 1: Carla Hall as a chef who survived a lobster attack, Zac Young as the big, bad wolf disguised as granny, Katie Lee as Captain Judgmental Episode 2: Carla Hall as Mother Earth, Zac Young as a pink flamingo, Katie Lee as a pop art painting Episode 3: Carla Hall as Morticia Addams, Zac Young as Uncle Fester, Katie Lee as Wednesday Addams Episode 4: Carla Hall as ghost reporter, Zac Young as Liza Minnelli, Katie Lee as injured influencer Episode 5: Carla Hall as the Ice Queen, Zac Young as a romance novel hunk, Katie Lee as vampire nanny (Scary Poppins) Episode 6: Carla Hall as a shower poof (loofah), Zac Young as croquembouche, Katie Lee as candy corn
Tidepool Web — a data visualisation platform that aggregates data from a wide range of diabetes devices, including insulin pumps, continuous glucose monitors and blood glucose meters, allowing users and clinicians to review trends over time. Tidepool Mobile — a companion mobile application for logging meals, exercise and other contextual information alongside device data. Tidepool Loop — an open-source automated insulin delivery system that links a compatible continuous glucose monitor with an insulin pump to automate basal insulin dosing based on glucose readings. Tidepool Loop received FDA 510(k) clearance, making it the first FDA-cleared open-source AID application.
Sources: en.wikipedia.org
The revolts culminated with the revolt in East Germany against the Marxist–Leninist regime of Erich Honecker and demands for the Berlin Wall to be torn down. The event in East Germany developed into a popular mass revolt with sections of the Berlin Wall being torn down and East and West Berliners uniting. Gorbachev's refusal to use Soviet forces based in East Germany to suppress the revolt was seen as a sign that the Cold War had ended. Honecker was pressured to resign from office and the new government committed itself to reunification with West Germany. The Marxist–Leninist regime of Nicolae Ceaușescu in Romania was forcefully overthrown in 1989 and Ceaușescu was executed. Almost Eastern Bloc regimes also fell during the Revolutions of 1989 (1988–1993). Unrest and eventual collapse of Marxism–Leninism also occurred in Yugoslavia, although for different reasons than those of the Warsaw Pact. The death of Josip Broz Tito in 1980 and the subsequent vacuum of strong leadership amidst an economic crisis allowed the rise of rival ethnic nationalism in the multinational country. The first leader to exploit such nationalism for political purposes was Slobodan Milošević, who used it to seize power as president of Serbia and demanded concessions to Serbia and Serbs by the other republics in the Yugoslav federation.
APP interacts with reelin, a protein implicated in a number of brain disorders, including Alzheimer's disease. APP specifically interacts with TRPC6 to inhibit its cleavage by γ-secretase and reduce Aβ production.
Inspired by their colleagues in Buffalo, workers at a Starbucks store in Mesa, Arizona, petitioned the NLRB for a union election on November 18, 2021, to be represented by Workers United. The organizing at the Mesa location stemmed from, in part, a well-liked manager being terminated after whistle-blowing on Starbucks' anti-union plan. Starbucks temporarily closed two stores participating in the union drive in October for renovations. The company claimed these closures were unrelated to the unionization efforts. Starbucks began working with Littler Mendelson, a self-described "union-busting firm", in October. Starbucks requested that the National Labor Relations Board include all Buffalo Starbucks locations in the union vote, however, the NLRB rejected this argument and declared store by store elections. Finally, on December 9, 2021, the workers at the Elmwood Avenue store became the first unionized Starbucks workers at a Starbucks owned location in the United States with a 19–8 vote. The Camp Road location voted 12–8 not to be in the union. Starbucks does have unionized locations in other countries. On December 13, workers at two Boston area locations petitioned the NLRB for union elections to be unionize with Workers United. The workers cited the win in Buffalo as inspiration for organizing. Workers in at least one location had most cards signed within a day. In February 2022, Starbucks fired seven workers in Memphis who had led the unionization effort and temporarily closed the store.
Sources: en.wikipedia.org
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.
The DAC form carries a maleimide group that binds albumin and extends circulation time. The non-DAC form lacks this group and clears much faster. Both share the same receptor-binding core.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Activation raises cyclic AMP and promotes growth hormone release. Normal feedback pathways remain part of the response.
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.